Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)

Background
The Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) is issued by the National Institutes of Health (NIH), specifically through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This program aims to provide support to current recipients of NIAMS-supported K01, K08, K23, and K25 awards during their second to fourth year. The goal is to enhance the capability of these scientists to conduct research as they transition to fully independent investigator status. The program allows for up to $100,000 in direct costs for a project period of up to two years and does not support clinical trials.

Grant Details
The R03 grant mechanism supports various types of projects including pilot and feasibility studies, secondary analysis of existing data, small self-contained research projects, development of research methodology, and new research technology. The funding is intended for projects that can be completed within a short timeframe with limited resources. Applications proposing clinical trials will be considered non-responsive and returned without review. Eligible applicants must demonstrate their growth as investigators and independence through this additional support.

Eligibility Requirements
Eligible applicants include only current NIAMS-supported K01, K08, K23 or K25 recipients in their second to fourth year of award. Institutions encouraged to apply include Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), among others. Individuals from diverse backgrounds are encouraged to apply.

Period of Performance
The maximum project period is two years.

Grant Value
The total value of the grant is up to $100,000 in direct costs for the entire project period.